Company intelligence / Profile preview
Pharma Bavaria International
Prien am Chiemsee, Bavaria, Germanypharma-bavaria.com ↗
- Ownership
- Private
- Employees
- ~58
- Development stage
- Other
01
Overview
Pharma Bavaria International commercially markets a diversified portfolio of more than 40 branded EU-manufactured pharmaceutical products (Rx, OTC, herbal/supplements, and medical devices) in over 40–45 countries, focusing on emerging markets; no proprietary clinical-stage R&D pipeline is disclosed.
- Therapeutic areas
- HematologyImmunologyWomen's HealthCardiovascularNeurologyInfectious DiseasesPulmonologyGastroenterologyOncology
- Modalities
- Small moleculeBiologicVaccineMedical device
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Pharma Bavaria International.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pharma Bavaria International.